Envestnet Asset Management Inc Harrow Health, Inc. Transaction History

Envestnet Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$5.75 - $7.74 $58,701 - $79,017	-10,209 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$6.77 - $8.66 $69,114 - $88,409	10,209 New	10,209 $70,000
Q3 2021 Oct 07, 2021	SELL	$6.99 - $10.6 $70,410 - $106,773	-10,073 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$6.68 - $11.07 $67,287 - $111,508	10,073 New	10,073 $94,000

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.